Study S002816

A Multi-center, Randomized, Double-blind, Placebo-controlled，Parallel-group Clinical Trial to Assess the Efficacy and Safety of Noiiglutide Injection in Obese Subjects Without Diabetes.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04799327
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: UNKNOWN
Enrollment: 254
Start: 2021-03-29
Primary completion: 2022-05-15
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.
Conditions: Obesity
Interventions: DRUG:SHR20004; DRUG:placebo
Results posted: FALSE

Registered primary outcomes

Change from baseline in body weight [Week 0, Week 24]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.